These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 17048303

  • 21. Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population.
    Ichimura M, Kaku H, Fukutani T, Koga H, Mukai T, Miyake I, Yamada K, Koda Y, Hiromatsu Y.
    Thyroid; 2008 Jun; 18(6):625-30. PubMed ID: 18578611
    [Abstract] [Full Text] [Related]

  • 22. The development of Graves' disease and the CTLA-4 gene on chromosome 2q33.
    Heward JM, Allahabadia A, Armitage M, Hattersley A, Dodson PM, Macleod K, Carr-Smith J, Daykin J, Daly A, Sheppard MC, Holder RL, Barnett AH, Franklyn JA, Gough SC.
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2398-401. PubMed ID: 10404810
    [Abstract] [Full Text] [Related]

  • 23. Remission of Graves' hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene.
    Kinjo Y, Takasu N, Komiya I, Tomoyose T, Takara M, Kouki T, Shimajiri Y, Yabiku K, Yoshimura H.
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2593-6. PubMed ID: 12050220
    [Abstract] [Full Text] [Related]

  • 24. Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms.
    Daroszewski J, Pawlak E, Karabon L, Frydecka I, Jonkisz A, Slowik M, Bolanowski M.
    Eur J Endocrinol; 2009 Nov; 161(5):787-93. PubMed ID: 19734241
    [Abstract] [Full Text] [Related]

  • 25. Association of the A/G polymorphism at position 49 in exon 1 of CTLA-4 with the susceptibility to unexplained recurrent spontaneous abortion in the Chinese population.
    Wang X, Lin Q, Ma Z, Hong Y, Zhao A, Di W, Lu P.
    Am J Reprod Immunol; 2005 Feb; 53(2):100-5. PubMed ID: 15790344
    [Abstract] [Full Text] [Related]

  • 26. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
    Villanueva R, Inzerillo AM, Tomer Y, Barbesino G, Meltzer M, Concepcion ES, Greenberg DA, MacLaren N, Sun ZS, Zhang DM, Tucci S, Davies TF.
    Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
    [Abstract] [Full Text] [Related]

  • 27. Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations.
    Bednarczuk T, Hiromatsu Y, Fukutani T, Jazdzewski K, Miskiewicz P, Osikowska M, Nauman J.
    Eur J Endocrinol; 2003 Jan; 148(1):13-8. PubMed ID: 12534352
    [Abstract] [Full Text] [Related]

  • 28. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus.
    Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke R, Herwig J, Usadel KH, Badenhoop K.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):143-6. PubMed ID: 8989248
    [Abstract] [Full Text] [Related]

  • 29. CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism.
    Vaidya B, Oakes EJ, Imrie H, Dickinson AJ, Perros P, Kendall-Taylor P, Pearce SH.
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):732-5. PubMed ID: 12780750
    [Abstract] [Full Text] [Related]

  • 30. The common -318C/T polymorphism in the promoter region of CTLA4 gene is associated with reduced risk of ophthalmopathy in Chinese Graves' patients.
    Han SZ, Zhang SH, Li R, Zhang WY, Li Y.
    Int J Immunogenet; 2006 Aug; 33(4):281-7. PubMed ID: 16893393
    [Abstract] [Full Text] [Related]

  • 31. Association of NFKB1 -94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease.
    Kurylowicz A, Hiromatsu Y, Jurecka-Lubieniecka B, Kula D, Kowalska M, Ichimura M, Koga H, Kaku H, Bar-Andziak E, Nauman J, Jarzab B, Ploski R, Bednarczuk T.
    Genes Immun; 2007 Oct; 8(7):532-8. PubMed ID: 17690684
    [Abstract] [Full Text] [Related]

  • 32. Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack?
    Bednarczuk T, Gopinath B, Ploski R, Wall JR.
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):3-19. PubMed ID: 17521325
    [Abstract] [Full Text] [Related]

  • 33. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese.
    Yanagawa T, Taniyama M, Enomoto S, Gomi K, Maruyama H, Ban Y, Saruta T.
    Thyroid; 1997 Dec; 7(6):843-6. PubMed ID: 9459626
    [Abstract] [Full Text] [Related]

  • 34. HLA-DRB1*03 is a susceptibility gene in patients with Graves' disease with and without ophthalmopathy.
    Yarman S, Oguz F, Carin M.
    Int J Immunogenet; 2007 Feb; 34(1):23-5. PubMed ID: 17284224
    [Abstract] [Full Text] [Related]

  • 35. The Role of FOXP3 Polymorphisms in Graves' Disease with or without Ophthalmopathy in a Turkish Population.
    Yaylacıoğlu Tuncay F, Serbest Ceylanoğlu K, Güntekin Ergün S, Ergün G, Konuk O.
    Turk J Ophthalmol; 2024 Apr 19; 54(2):69-75. PubMed ID: 38645270
    [Abstract] [Full Text] [Related]

  • 36. MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease.
    Allahabadia A, Heward JM, Nithiyananthan R, Gibson SM, Reuser TT, Dodson PM, Franklyn JA, Gough SC.
    Lancet; 2001 Sep 22; 358(9286):984-5. PubMed ID: 11583755
    [Abstract] [Full Text] [Related]

  • 37. Thyroid autoantibody production is influenced by exon 1 and promoter CTLA-4 polymorphisms in patients with Hashimoto's thyroiditis.
    Zaletel K, Krhin B, Gaberscek S, Hojker S.
    Int J Immunogenet; 2006 Apr 22; 33(2):87-91. PubMed ID: 16611252
    [Abstract] [Full Text] [Related]

  • 38. Cytotoxic T lymphocyte-associated molecule-4 polymorphism in Turkish patients with Hashimoto thyroiditis.
    Sahin M, Gursoy A, Erdogan MF.
    Int J Immunogenet; 2009 Apr 22; 36(2):103-6. PubMed ID: 19284444
    [Abstract] [Full Text] [Related]

  • 39. Genetic polymorphisms associated with cigarette smoking and the risk of Graves' disease.
    Bufalo NE, Santos RB, Cury AN, Andrade RA, Morari J, Morari EC, Leite JL, Monte O, Romaldini JH, Ward LS.
    Clin Endocrinol (Oxf); 2008 Jun 22; 68(6):982-7. PubMed ID: 17980001
    [Abstract] [Full Text] [Related]

  • 40. Association of CTLA-4 and IL-13 gene polymorphisms with Graves' disease and ophthalmopathy in Chinese children.
    Chong KK, Chiang SW, Wong GW, Tam PO, Ng TK, Hu YJ, Yam GH, Lam DS, Pang CP.
    Invest Ophthalmol Vis Sci; 2008 Jun 22; 49(6):2409-15. PubMed ID: 18296657
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.